New Zealand - English - Medsafe (Medicines Safety Authority)

boucher & muir (new zealand) limited t/a bnm group - oxytocin 5 iu/ml equivalent to 8.3 mcg/ml;   - solution for injection - 5 iu/ml - active: oxytocin 5 iu/ml equivalent to 8.3 mcg/ml   excipient: glacial acetic acid sodium acetate sodium chloride water for injection - antepartum: · induction of labour for medical reasons, e.g. in cases of post-term gestation, premature rupture of the membranes, pregnancy-induced hypertension (pre-eclampsia). · enhancement of labour in selected cases of uterine inertia. · oxytocin injection bp may also be indicated in early stage of pregnancy, as adjunctive therapy for management of incomplete, inevitable or missed abortion. postpartum: · during caesarean section, after the delivery of the child. · prevention and treatment of postpartum uterine atony and haemorrhage.

New Zealand - English - Medsafe (Medicines Safety Authority)

boucher & muir (new zealand) limited t/a bnm group - oxytocin 10 iu/ml equivalent to 16.6 mcg/ml;   - solution for injection - 10 iu/ml - active: oxytocin 10 iu/ml equivalent to 16.6 mcg/ml   excipient: glacial acetic acid sodium acetate sodium chloride water for injection - antepartum: · induction of labour for medical reasons, e.g. in cases of post-term gestation, premature rupture of the membranes, pregnancy-induced hypertension (pre-eclampsia). · enhancement of labour in selected cases of uterine inertia. · oxytocin injection bp may also be indicated in early stage of pregnancy, as adjunctive therapy for management of incomplete, inevitable or missed abortion. postpartum: · during caesarean section, after the delivery of the child. · prevention and treatment of postpartum uterine atony and haemorrhage.

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - oxytocin -

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - oxytocin -

Australia - English - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - oxytocin -

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - oxytocin, quantity: 10 iu/ml - injection, solution - excipient ingredients: acetic acid; chlorobutanol hemihydrate; water for injections - induction of labour; inadequate uterine effort; management of third stage of labour; post-partum haemorrhage.

Australia - English - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - oxytocin, quantity: 5 iu - injection, solution - excipient ingredients: glacial acetic acid; sodium acetate trihydrate; water for injections; sodium hydroxide - oxytocin is indicated for the induction of labour; inadequate uterine effort; management of third stage of labour; post-partum haemorrhage.

United States - English - NLM (National Library of Medicine)

fresenius kabi usa, llc - oxytocin (unii: 1jqs135eyn) (oxytocin - unii:1jqs135eyn) - oxytocin 10 [usp'u] in 1 ml -   oxytocin injection (synthetic) is indicated for the initiation or improvement of uterine contractions, where this is desirable and considered suitable, in order to achieve early vaginal delivery for fetal or maternal reasons.  it is indicated for (1) induction of labor in patients with a medical indication for the initiation of labor, such as rh problems, maternal diabetes, pre-eclampsia at or near term, when delivery is in the best interest of mother and fetus or when membranes are prematurely ruptured and delivery is indicated; (2) stimulation or reinforcement of labor, as in selected cases of uterine inertia; (3) adjunctive therapy in the management of incomplete or inevitable abortion.  in the first trimester, curettage is generally considered primary therapy.  in second trimester abortion, oxytocin infusion will often be successful in emptying the uterus.  other means of therapy, however, may be required in such cases. oxytocin injection (synthetic) is indicated to produce uterine contractions during t

United States - English - NLM (National Library of Medicine)

fresenius kabi usa, llc - oxytocin (unii: 1jqs135eyn) (oxytocin - unii:1jqs135eyn) - oxytocin 10 [usp'u] in 1 ml -   oxytocin injection (synthetic) is indicated for the initiation or improvement of uterine contractions, where this is desirable and considered suitable, in order to achieve early vaginal delivery for fetal or maternal reasons.  it is indicated for (1) induction of labor in patients with a medical indication for the initiation of labor, such as rh problems, maternal diabetes, pre-eclampsia at or near term, when delivery is in the best interest of mother and fetus or when membranes are prematurely ruptured and delivery is indicated; (2) stimulation or reinforcement of labor, as in selected cases of uterine inertia; (3) adjunctive therapy in the management of incomplete or inevitable abortion.  in the first trimester, curettage is generally considered primary therapy.  in second trimester abortion, oxytocin infusion will often be successful in emptying the uterus.  other means of therapy, however, may be required in such cases. oxytocin injection (synthetic) is indicated to produce uterine contractions during t

New Zealand - English - Medsafe (Medicines Safety Authority)

apotex nz ltd - oxytocin 10 iu/ml equivalent to 16.7 microgram/ml - solution for injection - 10 iu/ml - active: oxytocin 10 iu/ml equivalent to 16.7 microgram/ml excipient: acetic acid chlorobutanol hemihydrate water for injection - antepartum: - induction of labour for medical reasons, e.g. in cases of post-term gestation, premature rupture of the membranes, pregnancy-induced hypertension (pre-eclampsia). - enhancement of labour in selected cases of uterine inertia. - oxytocin may also be indicated in early stage of pregnancy, as adjunctive therapy for management of incomplete, inevitable or missed abortion.